Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti–phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy
Chunxiong Zheng, Qingguo Zhong, Ke Yi, et al.
Science Advances (2023) Vol. 9, Iss. 32
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR–Cas gene editing
Yu Zhao, Jie Qin, Daohan Yu, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 12, pp. 1869-1879
Closed Access | Times Cited: 22
A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
An antifouling membrane-fusogenic liposome for effective intracellular delivery in vivo
Huimin Kong, Chunxiong Zheng, Ke Yi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Liposomes as Immunotherapeutic Carriers: A Game-Changer in Cancer Therapy
Sepehr Hoseinzadeh Moghaddam, Abulfazl Vatankhah, Fatemeh Oroojalian, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106847-106847
Closed Access | Times Cited: 3
Tumor‐Associated Macrophages Nano‐Reprogrammers Induce “Gear Effect” to Empower Glioblastoma Immunotherapy
Yang Wang, Guangzhe Li, Jianlong Su, et al.
Small (2025)
Closed Access | Times Cited: 2
Emerging nanoparticle platforms for CpG oligonucleotide delivery
Mingqiang Li, Haochen Yao, Ke Yi, et al.
Biomaterials Science (2024) Vol. 12, Iss. 9, pp. 2203-2228
Closed Access | Times Cited: 15
Spatiotemporal release of non-nucleotide STING agonist and AKT inhibitor from implantable 3D-printed scaffold for amplified cancer immunotherapy
Haixia Wang, Zheng Liu, Youqiang Fang, et al.
Biomaterials (2024) Vol. 311, pp. 122645-122645
Closed Access | Times Cited: 12
CRISPR/Cas detection with nanodevices: moving deeper into liquid biopsy
Huimin Kong, Ke Yi, Rachel L. Mintz, et al.
Chemical Communications (2024) Vol. 60, Iss. 17, pp. 2301-2319
Closed Access | Times Cited: 10
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access | Times Cited: 1
Versatile PLGA‐Based Drug Delivery Systems for Tumor Immunotherapy
Yishu Wang, Xiaoming Hu, Jinghui Wang, et al.
Small Methods (2025)
Closed Access | Times Cited: 1
Bioactive Decellularized Extracellular Matrix Platform Integrating Multifunctional Nanozymes and Cell-Laden Microgels for Acute Liver Failure Treatment
Gang Xiao, Jiabin Zhang, Tong Lin, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Polymeric Nanoparticles Simultaneously Delivering Paclitaxel Prodrug and Combretastatin A4 with Exceptionally High Drug Loading for Cancer Combination Therapy
Huicong Zhou, Zhaofan Yang, Guan-Yu Jin, et al.
Nano Letters (2025)
Closed Access | Times Cited: 1
Ultrasound-nanovesicles interplay for theranostics
Jingyi Liu, Qing You, Fuming Liang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115176-115176
Closed Access | Times Cited: 7
Lysosome Targeted Nanoparticle Aggregation Reverses Immunosuppressive Tumor Microenvironment for Cancer Immunotherapy
Yumeng Xing, Jianhui Yang, Ao Peng, et al.
Advanced Materials (2024) Vol. 36, Iss. 47
Closed Access | Times Cited: 5
Functionalized extracellular nanovesicles as advanced CRISPR delivery systems
Siqing Wang, Huimin Kong, Chenya Zhuo, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3480-3499
Closed Access | Times Cited: 4
Immunomodulatory microneedle patch for enhanced Ferroptosis and immunogenic cell death in postoperative tumor therapy
Yuqin Wang, Quanmin Wang, Qingguo Zhong, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 766-776
Closed Access | Times Cited: 4
Prodrug-designed nanocarrier co-delivering chemotherapeutic and vascular disrupting agents with exceptionally high drug loading capacity
Huicong Zhou, Zhaofan Yang, Guan-Yu Jin, et al.
Journal of Controlled Release (2025), pp. 113628-113628
Closed Access
Membrane‐Anchoring and Oxygen‐Generating Mediated Nanosonosensitizer for Optimizing Cancer Immunotherapy
Qing Zhao, Ye ji Han, Wushuang Gong, et al.
Advanced Healthcare Materials (2025)
Closed Access
Radiation-triggerable bioreactors enable bioenergetic reprograming of cancer stem cell plasticity via targeted arginine metabolism disruption for augmented radio-immunotherapy
Xuemei Yao, Huocheng Yang, Sanxing Guo, et al.
Biomaterials (2025) Vol. 322, pp. 123391-123391
Closed Access
Fusogenic Lipid Nanovesicles as Multifunctional Immunomodulatory Platforms for Precision Solid Tumor Therapy
Ou Xu, Jiaxin Zhou, Hai‐Yan Xie, et al.
Small (2025)
Closed Access
Double-punch strategy: Macrophage membrane-enveloped imipramine and aCD47 reprograms tumor microenvironment to enhance glioblastoma immunotherapy
Long Zhang, Yining Zhang, Ji Qi, et al.
Chemical Engineering Journal (2025), pp. 163715-163715
Closed Access
Nanotherapeutics for Macrophage Network Modulation in Tumor Microenvironments: Targets and Tools
Renwei Li, Jing Huang, Yuhao Wei, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 13615-13651
Open Access | Times Cited: 2
Matairesinol repolarizes M2 macrophages to M1 phenotype to induce apoptosis in triple-negative breast cancer cells
Amol Chaudhary, Prajakta Patil, Prerna Raina, et al.
Immunopharmacology and Immunotoxicology (2024), pp. 1-15
Open Access | Times Cited: 1
Revolutionizing Therapy: Nanomaterials in Liposomes Redefine the Future of Medicinal Drugs
Jerusa Maria de Oliveira, Rener M.F. Duarte, Samaysa de Lima Lins, et al.
IntechOpen eBooks (2024)
Open Access
Aggregation-induced emission luminescence for angiography and atherosclerotic diagnosis
Yuxun Ding, Guanchu Ou, Dong Wang
iScience (2024) Vol. 27, Iss. 9, pp. 110719-110719
Open Access
Page 1 - Next Page

Scroll to top